AU4563793A - Bivalent living vaccines against bacterial intestinal pathogenic agents, process for preparing the same, plasmids and strains useful as base material - Google Patents

Bivalent living vaccines against bacterial intestinal pathogenic agents, process for preparing the same, plasmids and strains useful as base material

Info

Publication number
AU4563793A
AU4563793A AU45637/93A AU4563793A AU4563793A AU 4563793 A AU4563793 A AU 4563793A AU 45637/93 A AU45637/93 A AU 45637/93A AU 4563793 A AU4563793 A AU 4563793A AU 4563793 A AU4563793 A AU 4563793A
Authority
AU
Australia
Prior art keywords
bivalent
plasmids
preparing
base material
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45637/93A
Inventor
Himanshu Brahmbhatt
Kenneth Timmis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4563793A publication Critical patent/AU4563793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU45637/93A 1992-07-03 1993-07-02 Bivalent living vaccines against bacterial intestinal pathogenic agents, process for preparing the same, plasmids and strains useful as base material Abandoned AU4563793A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4221840 1992-07-03
DE4221840A DE4221840A1 (en) 1992-07-03 1992-07-03 Bivalent live vaccazines against bacterial intestinal pathogens, production methods and plasmids and strains as starting material
PCT/EP1993/001715 WO1994001562A1 (en) 1992-07-03 1993-07-02 Bivalent living vaccines against bacterial intestinal pathogenic agents, process for preparing the same, plasmids and strains useful as base material

Publications (1)

Publication Number Publication Date
AU4563793A true AU4563793A (en) 1994-01-31

Family

ID=6462385

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45637/93A Abandoned AU4563793A (en) 1992-07-03 1993-07-02 Bivalent living vaccines against bacterial intestinal pathogenic agents, process for preparing the same, plasmids and strains useful as base material

Country Status (3)

Country Link
AU (1) AU4563793A (en)
DE (1) DE4221840A1 (en)
WO (1) WO1994001562A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR950300072T1 (en) * 1995-10-13 1996-01-31 Schweiz Serum & Impfinst Recombinant live vaccines against Gram-negative enteric pathogens
WO2011092185A1 (en) * 2010-01-28 2011-08-04 Universiteit Gent Salmonella vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0250614A1 (en) * 1986-06-23 1988-01-07 Serum Und Impfinstitut Und Institut Zur Erforschung Der Infektionskrankheiten Schweiz. DNA fragments encoding the chromosomal nucleotide sugar synthetases and glycosyl transferases
EP0257837A1 (en) * 1986-08-19 1988-03-02 Enterovax Research Pty. Ltd. Hybrid bacterial strain

Also Published As

Publication number Publication date
WO1994001562A1 (en) 1994-01-20
DE4221840A1 (en) 1994-01-05

Similar Documents

Publication Publication Date Title
AU6373094A (en) Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use
AU1218295A (en) Adjuvant for antigens, process for producing the same and its use
AU5773290A (en) Medical material, process for its production, and medical device using the medical material
AU7239794A (en) Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent
AU8597791A (en) 3-alkoxyalkanoic acid derivative, process for preparing the same and herbicide using the same
AU1369997A (en) New phenylamidine derivatives, a process for preparing the same and their use as medicaments
AU2192588A (en) Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production
AU2980495A (en) Granular formulation containing microorganisms, a process for the preparation and the use thereof
AU8485291A (en) 4- or 5-substituted pyridine-2-carboxylic acids, a process for the preparation thereof and the use thereof as pharmaceuticals
AU2353995A (en) Process for the lysis of a culture of lactic acid bacteria by means of a lysin, and uses of the resulting lysed culture
AU8251591A (en) Novel pyrrolobenzimidazoles, imidazobenzoxazinones and imidazoquinolones, process for their preparation and their use and preparations containing the compounds
AU4563793A (en) Bivalent living vaccines against bacterial intestinal pathogenic agents, process for preparing the same, plasmids and strains useful as base material
AU4115796A (en) Iminooxymethylene anilides, process for preparing the same and their use
AU1446192A (en) Process for the production of antibiotics, dna-sequences, recombinant-dna-constructs and microbial strains used therein
AU2650788A (en) Adhesive composition, methods for the production and use thereof, and articles produced thereby
AU5717990A (en) Magnetic protein conjugates, a process for the preparation thereof and the use thereof
AU5217401A (en) Novel l-form bacterial strains, method for producing same and the use thereof for producing gene products
AU630725B2 (en) 2-amino-7-carbamoyl-1,2,3,4-tetrahydronaphthalenes, process for preparing them and their use as drugs
AU638082B2 (en) Thiazolyl-5-carbonamide derivatives, the preparation thereof composition containing them and their use against microorganisms
AU2975089A (en) Novel compounds, process for the preparation thereof and uses thereof
AU7186191A (en) Lactobacillus acidophilus F-133, lactic acid bacterium preparation prepared therefrom, and process for preparing the same
AU3218195A (en) Alpha-d-pentofuranoside derivatives, process for preparing the same and their use
AU1482392A (en) Process for the preparation of 2-pyridylsulfonylureas, and thiadiazoloptridines as intermediates in this process
EP0477717A3 (en) New 3-substituted cephalosporins, process for their preparation and their use as medicinal preparations
AU2413901A (en) Sterile product and process for preparing the product